Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AlloAid Nail is a human tissue allograft developed by AlloSource, specifically designed for the repair and reconstruction of the nail bed. It is derived from donated human nail tissue and processed to maintain its structural integrity while ensuring safety through rigorous screening and sterilization. The product serves as a natural scaffold that supports the regeneration of the patient's own nail or protects the underlying nail bed following trauma, avulsion, or surgical procedures. By providing a biocompatible surface, it helps reduce pain, prevents adhesion of the eponychial fold to the nail bed, and guides the growth of a new, functional nail. As a biological graft, it integrates with the host tissue to facilitate healing in cases of severe nail bed injuries where primary closure is not possible.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AlloAid Nail.